COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents

19/09/2024 - 15:45

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA Represents the second EMA approval of an MVA-BN-based vaccine for a younger population COPENHAGEN, [...]

Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board

19/09/2024 - 15:31

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis Dr. Comenzo was the lead [...]

FibroBiologics Engages Southern Star Research as CRO in Australia

19/09/2024 - 15:31

Southern Star Research will provide CRO services for FibroBiologics in Australia HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company [...]

Labviva Introduces Real Time Inventory Management System for Life Sciences Purchasing

19/09/2024 - 15:00

Enterprise procure-to-payment provider advances AI automation for inventory and purchase intelligence BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform for life sciences, today [...]

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

19/09/2024 - 15:00

CARMEL, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Floré Unveils World’s First Line of Probiotics for Neurodiversity

19/09/2024 - 15:00

New Science-Driven Products Result from Joint Autism Spectrum Disorder Research with Arizona State University SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré , a leader in gut health testing and customized [...]

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19/09/2024 - 15:00

Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians and [...]

International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate Myeloma Support for Patients, Care Partners, and Healthcare Professionals

19/09/2024 - 14:45

Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI Companion STUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce [...]

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults

19/09/2024 - 14:31

BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology [...]

Safety Shot Partners with Launchpad to Tap into the Large and Influential College Student Market

19/09/2024 - 14:30

Launchpad’s Network All Roads Travel (ART) Will Help Raise Brand Awareness for Safety Shot Among Millions of U.S. College Students JUPITER, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. (Nasdaq: SHOT) (“ [...]

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer

19/09/2024 - 14:30

Published data shows that chemotherapy delivered via TAMP with prior chemoradiation in Locally Advanced Pancreatic Cancer observed an Overall Survival of 27-months LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- [...]

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

19/09/2024 - 14:30

Topline results expected in fourth quarter of 2024 GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company [...]

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights

19/09/2024 - 14:30

- Fourth-quarter revenue of $0.73 million, up 64% year-over-year – - Full-year revenue of $3.11 million, up 148% year-over-year – - As of June 30, 2024, the Company had $6.30 million in cash - NEW YORK, Sept. 19, 2024 ( [...]

ARCPOINT ADDS FUNCTIONALITY TO ENABLE TELEHEALTH PRACTITIONERS TO ORDER DIAGNOTIC TESTS THROUGH ARCPOINT SYSTEM

18/09/2024 - 22:35

Greenville, South Carolina, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to report that it has implemented an integration that allows telehealth doctors and [...]

SOGC Statement on CMA Apology to Indigenous Peoples

18/09/2024 - 22:30

VICTORIA, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Today, the Society of Obstetricians and Gynaecologists of Canada (SOGC) stands in solidarity with the Canadian Medical Association (CMA) in its apology for [...]

Déclaration de la SOGC sur les excuses de l'AMC pour les torts causés aux peuples autochtones

18/09/2024 - 22:30

VICTORIA, C.-B., 18 sept. 2024 (GLOBE NEWSWIRE) -- Aujourd'hui, la Société des obstétriciens et gynécologues du Canada (SOGC) est solidaire avec l'Association médicale canadienne (AMC) dans ses excuses pour les torts [...]

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

18/09/2024 - 22:15

RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune system before [...]

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024

18/09/2024 - 22:15

NBTXR3 activé par radiothérapie suivi d’un anti-PD-1 a montré un profil de sécurité favorable, un contrôle de la maladie et une réponse tumorale chez les patients naïfs et résistants aux anti-PD-1, suggérant que NBTXR3 [...]

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

18/09/2024 - 22:09

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel, Sept. 18, 2024 (GLOBE [...]